>ABOUT TAKEDA >Our Management

Our Management

（ As of April 1, 2013 ）

Board members

Representative Director
President & CEO

Yasuchika Hasegawa

Managing Director
Internal Control and Special Missions assigned by President

Toyoji Yoshida

Managing Director
Assistant to CEO, Globalization

Yasuhiko Yamanaka

Director
Chief Commercial Officer
Executive Vice President of Takeda Pharmaceuticals International, Inc.
Chief Executive Officer, Takeda Pharmaceuticals International GmbH

Frank Morich, M.D, Ph.D.

Director
Chief Medical & Scientific Officer
Executive Vice President of Takeda Pharmaceuticals International, Inc.

Tadataka Yamada, M.D.

Director
Senior Vice President, Pharmaceutical Marketing Division

Masato Iwasaki

Director
President & CEO, Millennium Pharmaceuticals, Inc.

Deborah Dunsire, M.D.

Non-Executive Director
Honorary Advisor, JFE Holdings, Inc.

Fumio Sudo

Non-Executive Director
Chairman of the Board,
Mitsubishi Corporation

Yorihiko Kojima

Corporate Auditors

Corporate Auditor

Naohisa Takeda

Corporate Auditor

Teruo Sakurada

Corporate Auditor

Tadashi Ishikawa

Corporate Auditor

Tsuguoki Fujinuma

Corporate Officers

Haruhiko Hirate

 Senior Vice President
Head of North Asia, TPC

Nancy Joseph-Ridge, M.D.

 General Manager
Pharmaceutical Development Division

Anna Protopapas

 Executive Vice President
Global Business Development, Takeda Pharmaceuticals International, Inc.

Shinji Honda

 Senior Vice President,
Corporate Strategy Department

Trevor Smith

 Chief Executive Officer
Takeda Pharmaceuticals Europe Limited
Head of Europe and Canada Commercial
Operations, Takeda Pharmaceuticals International GmbH

Jostein Davidsen

 Head of Emerging Markets Commercial Operations, Takeda Pharmaceuticals International GmbH

Tadao Hirouchi

 Vice President, Pharmaceutical Marketing Division

Douglas Cole                                                                                

 President, Takeda Pharmaceuticals U.S.A., Inc.